Pacific Biosciences
PACB
#7724
Rank
S$0.56 B
Marketcap
S$1.81
Share price
2.94%
Change (1 day)
-2.53%
Change (1 year)

Pacific Biosciences (PACB) - Cash on Hand

Cash on Hand as of March 2026 : S$0.35 Billion

According to Pacific Biosciences 's latest financial reports the company has S$0.35 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Pacific Biosciences - Cash on Hand chart (from 2009 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31S$0.35 B-32.29%
2024-12-31S$0.53 B-36.44%
2023-12-31S$0.83 B-19.46%
2022-12-31S$1.03 B-26.67%
2021-12-31S$1.41 B234.76%
2020-12-31S$0.42 B537.17%
2019-12-31S$66.19 M-52.66%
2018-12-31S$0.13 B66.28%
2017-12-31S$84.09 M-19.28%
2016-12-31S$0.10 B-10.48%
2015-12-31S$0.11 B-13.1%
2014-12-31S$0.13 B-6.07%
2013-12-31S$0.14 B15.91%
2012-12-31S$0.12 B-46.47%
2011-12-31S$0.22 B-37.11%
2010-12-31S$0.36 B180.67%
2009-12-31S$0.13 B-14.16%
2008-12-31S$0.15 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Thermo Fisher Scientific
TMO
S$4.20 B 1,079.87%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
S$12.06 B 3,286.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
S$1.49 B 318.54%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
S$3.17 B 791.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Luminex
LMNX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
NanoString Technologies
NSTG
S$0.12 B-64.81%๐Ÿ‡บ๐Ÿ‡ธ USA